Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETHYLENEDIAMINE Cause Neoplasm malignant? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Neoplasm malignant have been filed in association with ETHYLENEDIAMINE. This represents 66.7% of all adverse event reports for ETHYLENEDIAMINE.

30
Reports of Neoplasm malignant with ETHYLENEDIAMINE
66.7%
of all ETHYLENEDIAMINE reports
10
Deaths
30
Hospitalizations

How Dangerous Is Neoplasm malignant From ETHYLENEDIAMINE?

Of the 30 reports, 10 (33.3%) resulted in death, 30 (100.0%) required hospitalization, and 10 (33.3%) were considered life-threatening.

Is Neoplasm malignant Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETHYLENEDIAMINE. However, 30 reports have been filed with the FAERS database.

What Other Side Effects Does ETHYLENEDIAMINE Cause?

Drug hypersensitivity (37) Drug ineffective (32) Drug intolerance (32) Condition aggravated (31) Hepatotoxicity (31) Musculoskeletal stiffness (31) Pain in extremity (31) Arthralgia (30) Infection (30) Joint swelling (30)

What Other Drugs Cause Neoplasm malignant?

RANITIDINE (10,648) ADALIMUMAB (2,028) APIXABAN (1,772) ETANERCEPT (1,616) METHOTREXATE (1,041) TOFACITINIB (1,020) RITUXIMAB (929) INFLIXIMAB (892) ABATACEPT (727) RISANKIZUMAB-RZAA (715)

Related Pages

ETHYLENEDIAMINE Full Profile All Neoplasm malignant Reports All Drugs Causing Neoplasm malignant ETHYLENEDIAMINE Demographics